Detalhe da pesquisa
1.
Tumor microenvironment and clinical efficacy of first line immunotherapy-based combinations in metastatic renal cell carcinoma.
Med Oncol
; 41(6): 150, 2024 May 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38740647
2.
Immune Checkpoint Inhibitor Rechallenge in Renal Cell Carcinoma: Current Evidence and Future Directions.
Cancers (Basel)
; 15(12)2023 Jun 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37370782
3.
Bone Metastases in Renal Cell Carcinoma: Impact of Immunotherapy on Survival.
Cancer Diagn Progn
; 3(5): 538-542, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37671314
4.
Clinico-Pathological Features Influencing the Prognostic Role of Body Mass Index in Patients With Advanced Renal Cell Carcinoma Treated by Immuno-Oncology Combinations (ARON-1).
Clin Genitourin Cancer
; 21(5): e309-e319.e1, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37062658
5.
Safety and Tolerability of COVID-19 Vaccines in Patients with Cancer: A Single Center Retrospective Analysis.
Vaccines (Basel)
; 10(6)2022 Jun 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35746500
6.
Concomitant Use of Statins, Metformin, or Proton Pump Inhibitors in Patients with Advanced Renal Cell Carcinoma Treated with First-Line Combination Therapies.
Target Oncol
; 17(5): 571-581, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35947324